Clinical Trials Logo

Clinical Trial Summary

Glutathione (a tripeptide of 3 amino acids - glutamic acid, cysteine and glycine) plays a great role in homeostasis, especially as a potent anti-oxidant.

As an anti-oxidant, it conjugates with xenobiotics using glutathione-S-transferase (GST) and excretes in urine as mercapturic acid.

In 1986, Casciani et al at the University of Milan, studied the effect of glutathione on blood alcohol, acetaldehyde and hepatic triglyceride levels and found a significant reducing effect.

The blood acetaldehyde, which is the metabolic product of ethyl alcohol may have a correlation with hangover symptoms. This study is designed to find this correlation using blood alcohol, blood acetaldehyde levels and the Hangover Symptoms Scale according to the Slutske et al study.


Clinical Trial Description

Type of Study: Double-blinded control

Population: 100 males

Inclusion Criteria:

- Males 20-40 years

- Healthy, without chronic diseases, especially must have normal hepatic function, measured by serum SGPT

- No history of alcoholic allergy

- Drink alcohol regularly, at least once a week

- Agree to be a subject by standard consent form

Exclusion Criteria:

- Subject wants to end the study

- Some impending danger to subjects

Number of subjects : 100

Methodology

1. Subjects are recruited;

2. History taking, physical examination and SGPT are done by M.D.;

3. 100 subjects are distributed randomly to numbers 1-100;

4. Factory provides 2 groups of capsules in randomized packets numbered 1 -100; each package contains 3 sub-packages; each sub-package contains 2 capsules of either placebo or 370 mg glutathione capsules. All the three sub-packages will be all placebo or all glutathione. 50 packages are placebo and 50 packages are glutathione;

5. Subjects are examined as follows:

- Hour 0: 3 ml of blood taken for blood alcohol and blood acetaldehyde;

- Hour 0- 1: consume Thai Whisky (40% alcohol) 60 ml with snacks;

- Hour 1: ml of blood taken for blood alcohol and blood acetaldehyde;

- Hour 1.30: ml of blood taken for blood alcohol and blood acetaldehyde;

- Hour 2.30: ml of blood taken for blood alcohol and blood acetaldehyde;

- Hour 3.30: ml of blood taken for blood alcohol and blood acetaldehyde;

- Hour 12: ml of blood taken for blood alcohol and blood acetaldehyde, and Alcohol Hangover Symptom evaluation of each subject is done individually.

Using Wendy S. Slutske et al Scale 0-4:

0= no symptom

1. minimal

2. some

3. much

4. most

Symptoms are

1. extreme thirst or dehydration

2. more tired than usual

3. headache

4. nausea

5. vomiting

6. very weak

7. difficulty concentrating

8. more sensitive to light and sound than usual

9. more sweating than usual

10. have a lot of trouble sleeping

11. anxious

12. depressed

13. trembling or shaking

Blood alcohol, blood acetaldehyde and hangover symptoms are statistically evaluated for significance. ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00127309
Study type Interventional
Source Piyavate Hospital
Contact
Status Completed
Phase N/A
Start date June 2005
Completion date August 2005

See also
  Status Clinical Trial Phase
Recruiting NCT05414344 - A Brief Intervention for Alcohol Users With Interpersonal Trauma N/A
Completed NCT05521906 - Evaluation of PRYSHM for LGBTQIA2S+ Youth N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Withdrawn NCT04659278 - Endourage Complete Spectrum Oral Mucosal Drops (OMD) in Adults Desiring a Reduction in Ethanol Use N/A
Not yet recruiting NCT03632408 - Hangover and Residual Zopiclone Effect on Spatial Perception Phase 1
Completed NCT02718508 - An e-Parenting Skills Intervention to Decrease Injured Adolescents' Alcohol Use N/A
Active, not recruiting NCT02629679 - Sports, Education and Consumption of Substances in Adolescents N/A
Completed NCT02945371 - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life N/A
Completed NCT01553136 - Varenicline Treatment of Alcohol Dependence in Smokers Phase 2
Completed NCT01442753 - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth N/A
Completed NCT01081119 - Brief Voluntary Alcohol and Drug Intervention for Middle School Youth Phase 2
Completed NCT04510116 - Adults In The Making Prevention Trial N/A
Completed NCT00289965 - Substance Use Risk Education (SURE) Project Phase 2
Completed NCT00506753 - Motivation and Skills for Delta-9-tetrahydrocannabinol/Ethanol (THC/ETOH+) Teens in Jail N/A
Recruiting NCT05288790 - Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT Phase 2
Recruiting NCT05620849 - Young Adult Education on Alcohol & Health N/A
Recruiting NCT03588754 - Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking? Phase 2
Recruiting NCT04054466 - Nursing Counseling to the Change of Behavior of Alcohol Consumption in Patients in HAART N/A
Recruiting NCT06074341 - TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study N/A
Terminated NCT04596267 - Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers Phase 1